Circulation

NOVEMBER 11, 2024

Evaluate the benefit in important cardiovascular outcomes and safety in elderly patients of a blood pressure control ≤ 130mmHg compared to standard of care.Methods:The research was performed in PubMed, EMBASE, Scielo, LILACS, and Cochrane Central Register of Controlled Trials (CENTRAL) from January 1st, 2013 to May 1st, 2023.

Blood Pressure 40

Blood Pressure Hypertension Kidney Disease Outcomes 40

Open Heart

SEPTEMBER 14, 2022

Aims To describe the use of warfarin and direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) and chronic kidney disease (CKD), to evaluate changes in renal function over time and predictors of rapid decline, and to describe time in therapeutic range (TTR) and predictors of poor TTR among patients on warfarin.

Kidney Disease 52

Kidney Disease Atrial Fibrillation Heart Failure Diabetes 52

DAIC

JANUARY 23, 2024

11 Despite the link between inflammation and cardiovascular disease has been proven by extensive research, most physicians have focused on treating high-risk patients with lipid lowering therapies including statin therapy.1,12,13 2013;368(21):2004-2013. Inflammation in coronary artery disease. Published 2013 Apr 4.

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Dr. Smith's ECG Blog

FEBRUARY 26, 2025

Mechanical complications such as free wall rupture, VSR and papillary muscle rupture is more likely to occur in patients who are older, female, hypertensive, have chronic kidney disease, and have no prior history of smoking. References: [1] Lador, A. The American Journal of Cardiology , 121 (6), 690694. link] [2] Oliva, P. Hammill, S.

Chest Pain 88

Chest Pain Pericarditis Myocardial Infarction Dementia 88